There have been 50 recent insider transactions recorded for Catalyst Pharmaceuticals, Inc. (CPRX), including 19 buys and 29 sells. Total insider buying was valued at $21.97M and total insider selling at $15.41M.
Notable insiders with recent activity include Russo Gregg, Daly Richard J, Kalb Michael Wayne. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CPRX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-17 |
Russo Gregg |
Chief HR Officer |
Tax Withholding of RSU |
211 |
- |
- |
476 |
| 2026-01-05 |
Daly Richard J |
President and CEO |
Tax Withholding of RSU |
10,577 |
- |
- |
271,266 |
| 2026-01-05 |
Kalb Michael Wayne |
Executive Vice President & CFO |
Tax Withholding of RSU |
2,080 |
- |
- |
13,665 |
| 2025-12-29 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Option Exercise (Sell) |
26,334 |
- |
- |
1,851,948 |
| 2025-12-29 |
Denkhaus Donald A |
Director |
Option Exercise (Sell) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Tierney David S |
Director |
Option Exercise (Sell) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Miller Steve |
Chief Op. & Scientific Officer |
Option Exercise |
14,000 |
- |
- |
1,093,803 |
| 2025-12-29 |
Daly Richard J |
President and CEO |
Tax Withholding of RSU |
524 |
- |
- |
239,738 |
| 2025-12-29 |
Elsbernd Brian |
Chief Compliance/legal Officer |
Tax Withholding of RSU |
2,623 |
- |
- |
242,501 |
| 2025-12-29 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Tax Withholding of RSU |
3,839 |
- |
- |
14,337 |
| 2025-12-29 |
Harper Molly |
Director |
Option Exercise |
1,334 |
- |
- |
3,694 |
| 2025-12-29 |
Sundaram Preethi |
Chief Strategy Officer |
Tax Withholding of RSU |
2,369 |
- |
- |
54,804 |
| 2025-12-12 |
Harper Molly |
Director |
Informative Sell |
6,746 |
$23.06 |
$155.56K |
2,360 |
| 2025-12-08 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Option Exercise (Sell) |
3,534 |
- |
- |
1,878,282 |
| 2025-12-08 |
Denkhaus Donald A |
Director |
Option Exercise (Sell) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Tierney David S |
Director |
Option Exercise (Sell) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Miller Steve |
Chief Op. & Scientific Officer |
Option Exercise |
11,873 |
- |
- |
1,079,803 |
| 2025-12-08 |
Elsbernd Brian |
Chief Compliance/legal Officer |
Tax Withholding of RSU |
2,780 |
- |
- |
238,457 |
| 2025-12-08 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Tax Withholding of RSU |
2,492 |
- |
- |
9,509 |
| 2025-12-08 |
Thompson Tamar |
Director |
Option Exercise |
1,413 |
- |
- |
3,773 |
| 2025-12-08 |
Harper Molly |
Director |
Option Exercise |
1,413 |
- |
- |
9,106 |
| 2025-12-08 |
Sundaram Preethi |
Chief Strategy Officer |
Tax Withholding of RSU |
1,669 |
- |
- |
50,506 |
| 2025-12-01 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Gift (Given) |
45,000 |
- |
- |
4,148,477 |
| 2025-11-26 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Informative Sell |
10,983 |
$23.33 |
$256.24K |
3,962 |
| 2025-11-21 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Option Exercise (Sell) |
1,775 |
- |
- |
1,881,816 |
| 2025-11-21 |
Tierney David S |
Director |
Option Exercise (Sell) |
947 |
- |
- |
180,910 |
| 2025-11-21 |
Miller Steve |
Chief Op. & Scientific Officer |
Option Exercise |
8,267 |
- |
- |
1,067,930 |
| 2025-11-21 |
Daly Richard J |
President and CEO |
Option Exercise |
20,006 |
- |
- |
246,800 |
| 2025-11-21 |
Kalb Michael Wayne |
Executive Vice President & CFO |
Tax Withholding of RSU |
2,485 |
- |
- |
8,606 |
| 2025-11-21 |
Thompson Tamar |
Director |
Option Exercise |
947 |
- |
- |
2,360 |
| 2025-11-21 |
Harper Molly |
Director |
Option Exercise |
947 |
- |
- |
7,693 |
| 2025-11-21 |
Sundaram Preethi |
Chief Strategy Officer |
Tax Withholding of RSU |
1,364 |
- |
- |
45,320 |
| 2025-11-20 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
RSU Award |
34,921 |
$22.77 |
$795.15K |
1,873,051 |
| 2025-11-20 |
Tierney David S |
Director |
RSU Award |
18,115 |
$22.77 |
$412.48K |
176,389 |
| 2025-11-20 |
Miller Steve |
Chief Op. & Scientific Officer |
RSU Award |
158,454 |
$22.77 |
$3.61M |
1,457,963 |
| 2025-11-20 |
Daly Richard J |
President and CEO |
RSU Award |
381,948 |
$22.77 |
$8.7M |
2,546,695 |
| 2025-11-20 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU Award |
131,536 |
$22.77 |
$3M |
607,235 |
| 2025-11-20 |
Thompson Tamar |
Director |
RSU Award |
18,115 |
$22.77 |
$412.48K |
116,555 |
| 2025-11-20 |
Harper Molly |
Director |
RSU Award |
18,115 |
$22.77 |
$412.48K |
145,389 |
| 2025-11-20 |
Sundaram Preethi |
Chief Strategy Officer |
RSU Award |
106,873 |
$22.77 |
$2.43M |
785,305 |
| 2025-11-20 |
Russo Gregg |
Chief HR Officer |
RSU Award |
20,531 |
$22.77 |
$467.49K |
66,276 |
| 2025-06-11 |
Sundaram Preethi |
Chief Strategy Officer |
Informative Sell |
1,600 |
$26.42 |
$42.27K |
41,081 |
| 2025-06-10 |
Sundaram Preethi |
Chief Strategy Officer |
Informative Sell |
2,324 |
$26.41 |
$61.38K |
42,681 |
| 2025-06-09 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Informative Sell |
171,748 |
$26.11 |
$4.48M |
4,281,702 |
| 2025-06-06 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Informative Sell |
28,252 |
$25.95 |
$733K |
4,453,450 |
| 2025-06-02 |
Andrews William T. |
Chief Medical Officer |
Unknown |
15,261 |
- |
- |
- |
| 2025-05-30 |
Daly Richard J |
President and CEO |
Informative Buy |
70,000 |
$24.86 |
$1.74M |
199,764 |
| 2025-05-14 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informative Sell |
44,000 |
$23.63 |
$1.04M |
68,873 |
| 2025-05-13 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informative Sell |
200,000 |
$23.68 |
$4.74M |
68,873 |
| 2025-03-06 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informative Sell |
180,096 |
$21.67 |
$3.9M |
68,873 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
